Developmental Disabilities

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-10-24
Clinical Trial Update: Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities [Phase 4]
Phase 4 trial of valbenazine for tardive dyskinesia in adults with intellectual/developmental disabilities has been withdrawn.